The Washington PostThe Washington Post

Some long-covid patients oppose an exercise trial aiming to help them

By Amanda Morris

22 May 2023 · 6 min read

The Washington Post reports on a proposed exercise trial for long-covid patients. Some people fear that such a trial could be dangerous for patients suffering from myalgic encephalomyelitis (ME/CFS).

Curated by informed

A proposed exercise trial for long covid is being criticized by some of the patients the government-funded researchers want to study.

The trial is part of the Researching COVID to Enhance Recovery (RECOVER) initiative, funded by the government for $1.15 billion over four years. It aims to study long covid and help find treatments for the millions of people experiencing a range of long-lasting symptoms, including extreme fatigue, brain fog and shortness of breath.

The news, curated.

Subscribe in our mobile app to continue reading this The Washington Post article

Already subscribed? Sign in

Get world-class journalism from premium publishers, curated by editors and experts. All in one app.

Subscribe now and get 14 days free.